The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

Background Renal function declines progressively in patients who have diabetic nephropathy, and the decline may be slowed by antihypertensive drugs. The purpose of this study was to determine whether captopril has kidney-protecting properties independent of its effect on blood pressure in diabetic nephropathy. Methods We performed a randomized, controlled trial comparing captopril with placebo in patients with insulin-dependent diabetes mellitus in whom urinary protein excretion was ≥ 500 mg per day and the serum creatinine concentration was ≤ 2.5 mg per deciliter (221 μmol per liter). Blood-pressure goals were defined to achieve control during a median follow-up of three years. The primary end point was a doubling of the base-line serum creatinine concentration. Results Two hundred seven patients received captopril, and 202 placebo. Serum creatinine concentrations doubled in 25 patients in the captopril group, as compared with 43 patients in the placebo group (P =0.007). The associated reductions in risk...

[1]  C. Mogensen.  Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. , 1976, Scandinavian journal of clinical and laboratory investigation.

[2]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[3]  Danyu Lin,et al.  Goodness-of-Fit Analysis for the Cox Regression Model Based on a Class of Parameter Estimators , 1991 .

[4]  B. Brenner,et al.  Short and long term effects of antihypertensive therapy in the diabetic rat. , 1989, Kidney international.

[5]  L. Ruilope,et al.  Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[7]  H. Parving,et al.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. , 1991, BMJ.

[8]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[9]  C. Mogensen.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[10]  J. Ménard,et al.  Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. , 1988, BMJ.

[11]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[12]  G. Remuzzi,et al.  Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? , 1990, Kidney international.

[13]  G. Remuzzi,et al.  Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. , 1990, The Journal of clinical investigation.

[14]  A. Fogo,et al.  Evidence for the central role of glomerular growth promoters in the development of sclerosis. , 1989, Seminars in nephrology.

[15]  David R. Cox.  The analysis of binary data , 1970 .

[16]  A. Krolewski,et al.  Hypertension: The Major Risk Factor in Juvenile-onset Insulin-dependent Diabetics , 1981, Diabetes.

[17]  B. Brenner,et al.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[19]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[20]  R. B. Payne.  Creatinine Clearance: A Redundant Clinical Investigation , 1986, Annals of Clinical Biochemistry.

[21]  H. Parving,et al.  Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. , 1989, BMJ.

[22]  A. Fogo,et al.  Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. , 1990, Kidney international.

[23]  H. Parving,et al.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. , 1988, BMJ.

[24]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[25]  G. Nyberg,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[26]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[27]  Y. Taguma,et al.  Effect of captopril on heavy proteinuria in azotemic diabetics. , 1985, The New England journal of medicine.

[28]  B. Berk,et al.  Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. , 1989, Hypertension.

[29]  H. Parving,et al.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. , 1986, British medical journal.

[30]  L. J. Wei,et al.  Properties of the urn randomization in clinical trials. , 1988, Controlled clinical trials.